Machine Learning Approach to Stratifying Prognosis Relative to Tumor Burden after Resection of Colorectal Liver Metastases: An International Cohort Analysis.

四分位间距 医学 队列 内科学 总体生存率 肿瘤科 肝切除术 放射科
作者
Alessandro Paro,Madison J Hyer,Diamantis I Tsilimigras,Alfredo Guglielmi,Andrea Ruzzenente,Sorin Alexandrescu,George Poultsides,Federico Aucejo,Jordan M Cloyd,Timothy M Pawlik
出处
期刊:Journal of The American College of Surgeons [Lippincott Williams & Wilkins]
卷期号:234 (4): 504-513
标识
DOI:10.1097/xcs.0000000000000094
摘要

Assessing overall tumor burden on the basis of tumor number and size may assist in prognostic stratification of patients after resection of colorectal liver metastases (CRLM). We sought to define the prognostic accuracy of tumor burden by using machine learning (ML) algorithms compared with other commonly used prognostic scoring systems.Patients who underwent hepatectomy for CRLM between 2001 and 2018 were identified from a multi-institutional database and split into training and validation cohorts. ML was used to define tumor burden (ML-TB) based on CRLM tumor number and size thresholds associated with 5-year overall survival. Prognostic ability of ML-TB was compared with the Fong and Genetic and Morphological Evaluation scores using Cohen's d.Among 1,344 patients who underwent resection of CRLM, median tumor number (2, interquartile range 1 to 3) and size (3 cm, interquartile range 2.0 to 5.0) were comparable in the training (n = 672) vs validation (n = 672) cohorts; patient age (training 60.8 vs validation 61.0) and preoperative CEA (training 10.2 ng/mL vs validation 8.3 ng/mL) was also similar (p > 0.05). ML empirically derived optimal cutoff thresholds for number of lesions (3) and size of the largest lesion (1.3 cm) in the training cohort, which were then used to categorize patients in the validation cohort into 3 prognostic groups. Patients with low, average, or high ML-TB had markedly different 5-year overall survival (51.6%, 40.9%, and 23.1%, respectively; p < 0.001). ML-TB was more effective at stratifying patients relative to 5-year overall survival (low vs high ML-TB, d = 2.73) vs the Fong clinical (d = 1.61) or Genetic and Morphological Evaluation (d = 0.84) scores.Using a large international cohort, ML was able to stratify patients into 3 distinct prognostic categories based on overall tumor burden. ML-TB was noted to be superior to other CRLM prognostic scoring systems.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
极乐鸟发布了新的文献求助10
2秒前
沫沫完成签到 ,获得积分0
3秒前
3秒前
105完成签到 ,获得积分0
6秒前
wmc1357发布了新的文献求助10
9秒前
yuxi2025完成签到 ,获得积分10
14秒前
小爱完成签到,获得积分10
16秒前
极乐鸟完成签到,获得积分20
17秒前
搜集达人应助狂野灵波采纳,获得10
18秒前
吴谷杂粮完成签到 ,获得积分10
19秒前
晚意完成签到 ,获得积分10
19秒前
20秒前
任性的思远完成签到 ,获得积分10
21秒前
jinjing完成签到,获得积分10
24秒前
zhang完成签到 ,获得积分10
24秒前
s_yu完成签到,获得积分10
25秒前
flj7038完成签到,获得积分10
26秒前
27秒前
clm完成签到 ,获得积分10
27秒前
搜集达人应助cheng采纳,获得10
29秒前
年轻花卷完成签到,获得积分10
29秒前
laohu完成签到,获得积分10
29秒前
萧幻枫完成签到 ,获得积分10
32秒前
灵巧的长颈鹿完成签到,获得积分10
32秒前
36秒前
呼呼完成签到,获得积分10
36秒前
L_完成签到 ,获得积分10
38秒前
cheng发布了新的文献求助10
40秒前
41秒前
cdercder应助科研通管家采纳,获得10
42秒前
无极微光应助科研通管家采纳,获得20
42秒前
cdercder应助科研通管家采纳,获得10
42秒前
cdercder应助科研通管家采纳,获得10
42秒前
44秒前
拉长的芷烟完成签到 ,获得积分10
45秒前
伶俐书蝶完成签到 ,获得积分10
46秒前
jeery完成签到 ,获得积分10
50秒前
ira完成签到,获得积分10
1分钟前
film完成签到 ,获得积分10
1分钟前
高分求助中
Adhesion Science: Principles & Practice 1234
Signals, Systems, and Signal Processing 610
Burger's Medicinal Chemistry and Drug Discovery 400
A Step-by-Step Guide to Qualitative Data Coding 2nd Edition 400
Impact of Storage Orientation and Duration on Prefilled Syringe Performance: Break-Loose and Glide Forces, and Injection Time Across Multiple Time Points 360
Programming for Chemical Engineers Using C, C++, and MATLAB 300
Upland Kenya wild flowers and ferns: a flora of the flowers, ferns, grasses, and sedges of highland Kenya 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6662938
求助须知:如何正确求助?哪些是违规求助? 8413037
关于积分的说明 17984348
捐赠科研通 5866763
什么是DOI,文献DOI怎么找? 2974939
邀请新用户注册赠送积分活动 1950845
关于科研通互助平台的介绍 1876490